ALX Oncology Holdings Inc (ALXO) stock
ALXONasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.97−0.03 (-3.47%)
Close on Nov 18, 2026Market cap $134.14MP/E –Yield –
ALX Oncology profit margin
Profit margin (net margin) is net income as a percentage of revenue.
ALX Oncology's profit margin for the twelve months ending Dec 31, 2020 was -3869.7%. For fiscal 2020 it was -3869.7%, against -401.2% the year before.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2020 | Dec 31, 2020 | -3869.7% | −3468.5 |
| FY2019 | Dec 31, 2019 | -401.2% | +263.1 |
| FY2018 | Dec 31, 2018 | -664.3% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2020 | Jun 30, 2020 | -2150.1% | −1826.0 |
| Q1 FY2020 | Mar 31, 2020 | -832.7% | – |
| Q4 FY2019 | Dec 31, 2019 | -640.1% | – |
| Q3 FY2019 | Sep 30, 2019 | -242.4% | – |
| Q2 FY2019 | Jun 30, 2019 | -324.1% | – |
See a number that looks wrong?